Welcome to our dedicated page for Veradigm news (Ticker: MDRX), a resource for investors and traders seeking the latest updates and insights on Veradigm stock.
Veradigm Inc. (MDRX) is a healthcare technology company that focuses on healthcare data and technology solutions for providers, payers, and biopharma organizations. News about Veradigm often centers on how the company uses its platforms, data, connectivity, and expertise within the Veradigm Network to support clinical, operational, and financial performance in healthcare.
Investors and industry observers following MDRX news can expect updates on business performance, financing, and capital structure, as reflected in Veradigm’s announcements about financial outlooks, cash and debt levels, and debt financing arrangements. The company also issues news about its progress on financial reporting, including the filing of its Annual Report on Form 10-K with restated financial statements and its efforts to become current in SEC filings and pursue relisting on a national stock exchange.
Operational and client-focused news includes case studies and collaborations that highlight Veradigm’s role in value-based care, payer–provider integration, and revenue cycle management. Examples include recognition through a KLAS Points of Light Award for delivering insights at the point of care and announcements about organizations selecting Veradigm Revenue Cycle Services, Coding Services, and related offerings such as Veradigm Revenue Analytics, Veradigm Practice Management, and Veradigm Payerpath.
Veradigm also issues news on product and capability developments, such as applying artificial intelligence to deidentified EHR data to generate real-world evidence for GLP-1 therapies, and on thought leadership initiatives like the Smart Medicine Podcast. Governance and corporate updates, including leadership appointments and amendments to the company’s stockholder rights plan, are additional recurring themes. For a comprehensive view of MDRX-related developments, this news page aggregates these announcements and related coverage in one place.
Allscripts Healthcare (NASDAQ: MDRX) has partnered with Revo Health to enhance the financial and operational performance of i-Health clinics. This collaboration will integrate Allscripts Practice Management and Payerpath, aiming to optimize workflows and boost productivity. i-Health operates various medical specialties, and Revo supports them by managing several departments, including HR and Revenue Cycle. The partnership is expected to help both organizations focus on delivering quality patient care while improving their bottom line through effective healthcare solutions.
Allscripts Healthcare Solutions (NASDAQ: MDRX) has been selected by Mercy Iowa City to implement the Allscripts Sunrise platform, powered by Microsoft Azure, as its core electronic health record (EHR). This partnership aims to enhance care delivery and simplify technology for the community hospital, which serves a large patient base in Eastern Iowa. Mercy Iowa City emphasizes a commitment to integrated care, and Allscripts' Sunrise EHR promises improved clinician experiences and patient outcomes through its comprehensive and interoperable platform.
Allscripts (NASDAQ: MDRX) has been recognized as the top electronic health record vendor for community hospitals, marking its fifth consecutive year at this position, as per the latest Black Book Research survey. The survey, conducted with over 1,800 community hospitals, highlighted Allscripts' leading performance in 10 out of 18 key indicators, including trust, innovation, and data security. The results reflect Allscripts' commitment to supporting community hospitals amid rising operational costs and complexity in healthcare delivery.
Allscripts Healthcare Solutions (MDRX) reported its Q4 2020 results, showing bookings of $220 million, down from $312 million in Q4 2019. GAAP revenue decreased to $386 million, while non-GAAP revenue fell to $415 million. The company posted a GAAP loss from operations of $68 million, up from a loss of $55 million in the prior year. However, GAAP net income reached $728 million, a significant improvement from a $19 million loss in Q4 2019. For 2021, Allscripts expects revenue of $1.5 billion and adjusted EBITDA of $240-$260 million.
Allscripts Healthcare Solutions (NASDAQ: MDRX) hosted Israeli President Reuven Rivlin and Beer Sheva Mayor Ruvik Danilovich to discuss their dbMotion interoperability solution, which connects 30 health organizations nationwide. This enhanced epidemiological capabilities during the COVID-19 pandemic, aiding the Ministry of Health. dbMotion facilitates over 14M patient transactions monthly, serving 31,000+ providers and 1,000+ hospitals. Allscripts aims to support healthcare delivery amidst challenges, emphasizing their commitment to innovation and effective data sharing.
Pulse8, part of Veradigm, has received MY 2020 Measure Certification from the NCQA for its Qualit8 product. This certification enhances their offerings by integrating established Quality Improvement Analytics with NCQA-certified HEDIS Measurement and Reporting Software. The new solution will streamline operations for health plan customers by processing all HEDIS MY 2020 measures and providing improved administrative efficiency. Pulse8 aims to eliminate unnecessary interventions, enhancing focus on critical health care elements.
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) will announce its financial results for Q4 and full-year 2020 on February 25, 2021, after market close. A conference call to discuss the earnings will be held at 4:30 p.m. ET the same day. The announcement will be available on the Allscripts investor relations website. Interested participants can join the call by dialing (877) 269-7756 or (201) 689-7817, using Conference ID #13715828. A replay will be accessible for four weeks post-call.
ConnectiveRx has partnered with Veradigm, a unit of Allscripts (NASDAQ: MDRX), to enhance patient access to prescription-related information. The three-year agreement, effective from March 1, 2021, allows ConnectiveRx to deliver electronic coupons to over 130 million patients via Allscripts’ EHR platforms. In 2020, over 200 million electronic prescriptions were processed through the Allscripts network. This partnership aims to improve medication adherence and awareness, benefiting both healthcare providers and patients.
Allscripts Healthcare Solutions (NASDAQ: MDRX), along with MATTER, Microsoft, and the ARC Innovation Center at Sheba Medical Center, hosted a virtual pitch competition centered on innovative health IT solutions. In honor of Florence Nightingale's legacy, eight organizations presented ideas to enhance electronic health records and lessen nurses' workloads. DeepScribe won the challenge with its AI-powered medical scribe, receiving multiple benefits, including marketing support and opportunity to present its solution to experts. Allscripts emphasizes the importance of innovation in healthcare delivery.
Allscripts Healthcare Solutions (NASDAQ: MDRX) has partnered with US Orthopedic Alliance (USOA) to enhance orthopedic practices across the nation. This collaboration aims to provide state-of-the-art technology solutions, improve EHR implementation, and foster community-wide connectivity with value-based care analytics. USOA, serving over 100 orthopedic surgeons and multiple facilities, will leverage Allscripts' expertise to create a scalable platform that enhances operational efficiency while prioritizing patient-centered care.